Catalyst Pharmaceutical
CPRX
CPRX
334 hedge funds and large institutions have $2.04B invested in Catalyst Pharmaceutical in 2024 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 139 increasing their positions, 92 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
334
Holders Change
+21
Holders Change %
+6.71%
% of All Funds
4.45%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
60
Increased
139
Reduced
92
Closed
36
Calls
$490K
Puts
$248K
Net Calls
+$242K
Net Calls Change
+$1.21M
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$58.5M |
| 2 |
2
Bank of America
Charlotte,
North Carolina
|
$32.7M |
| 3 |
3
Macquarie Group
Sydney, NSW 2000,
Australia
|
$14.2M |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$15.1M |
| 5 |
5
Aberdeen Group
Edinburgh,
United Kingdom
|
$10.1M |
